Similar articles

• Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.

  Wang Z, Yue Y, Han P, Sa R, Ren X, Wang J, Bai H, Yu H. Wang Z, et al. Cytotherapy. 2013 Sep;15(9):1164-73. doi: 10.1016/j.jcyt.2013.05.001. Epub 2013 Jun 22. Cytotherapy. 2013. PMID: 23800731
• Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.

  Takai N, Kawamata N, Walsh CS, Gery S, Desmond JC, Whittaker S, Said JW, Popoviciu LM, Jones PA, Miyakawa I, Koeffler HP. Takai N, et al. Mol Cancer Res. 2005 May;3(5):261-9. doi: 10.1158/1541-7786.MCR-04-0110. Mol Cancer Res. 2005. PMID: 15886297
• Integrated analysis of genetic and epigenetic alterations in cancer.

  Toyota M, Suzuki H, Yamamoto E, Yamano H, Imai K, Shinomura Y. Toyota M, et al. Epigenomics. 2009 Dec;1(2):291-9. doi: 10.2217/epi.09.20. Epigenomics. 2009. PMID: 22122704 Review.
• Momentum building for human epigenome project.

  Garber K. Garber K. J Natl Cancer Inst. 2006 Jan 18;98(2):84-6. doi: 10.1093/jnci/djj042. J Natl Cancer Inst. 2006. PMID: 16418505 No abstract available.
• [Epigenetic modifications in lung cancer].

  Brambilla E. Brambilla E. Ann Pathol. 2009 Nov;29 Spec No 1:S31-3. doi: 10.1016/j.annpat.2009.07.010. Epub 2009 Oct 6. Ann Pathol. 2009. PMID: 19887246 Review. French. No abstract available.